330 related articles for article (PubMed ID: 15944382)
1. Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.
Smith WW; Margolis RL; Li X; Troncoso JC; Lee MK; Dawson VL; Dawson TM; Iwatsubo T; Ross CA
J Neurosci; 2005 Jun; 25(23):5544-52. PubMed ID: 15944382
[TBL] [Abstract][Full Text] [Related]
2. Casein kinase II-mediated phosphorylation regulates alpha-synuclein/synphilin-1 interaction and inclusion body formation.
Lee G; Tanaka M; Park K; Lee SS; Kim YM; Junn E; Lee SH; Mouradian MM
J Biol Chem; 2004 Feb; 279(8):6834-9. PubMed ID: 14645218
[TBL] [Abstract][Full Text] [Related]
3. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.
Chung KK; Zhang Y; Lim KL; Tanaka Y; Huang H; Gao J; Ross CA; Dawson VL; Dawson TM
Nat Med; 2001 Oct; 7(10):1144-50. PubMed ID: 11590439
[TBL] [Abstract][Full Text] [Related]
4. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
[TBL] [Abstract][Full Text] [Related]
5. Synphilin-1 isoforms in Parkinson's disease: regulation by phosphorylation and ubiquitylation.
Szargel R; Rott R; Engelender S
Cell Mol Life Sci; 2008 Jan; 65(1):80-8. PubMed ID: 17982729
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
[TBL] [Abstract][Full Text] [Related]
7. Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation.
Szargel R; Rott R; Eyal A; Haskin J; Shani V; Balan L; Wolosker H; Engelender S
J Biol Chem; 2009 Apr; 284(17):11706-16. PubMed ID: 19224863
[TBL] [Abstract][Full Text] [Related]
8. Synphilin isoforms and the search for a cellular model of lewy body formation in Parkinson's disease.
Eyal A; Engelender S
Cell Cycle; 2006 Sep; 5(18):2082-6. PubMed ID: 16969096
[TBL] [Abstract][Full Text] [Related]
9. Prolyl-isomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of alpha-synuclein inclusions.
Ryo A; Togo T; Nakai T; Hirai A; Nishi M; Yamaguchi A; Suzuki K; Hirayasu Y; Kobayashi H; Perrem K; Liou YC; Aoki I
J Biol Chem; 2006 Feb; 281(7):4117-25. PubMed ID: 16365047
[TBL] [Abstract][Full Text] [Related]
10. Dorfin localizes to Lewy bodies and ubiquitylates synphilin-1.
Ito T; Niwa J; Hishikawa N; Ishigaki S; Doyu M; Sobue G
J Biol Chem; 2003 Aug; 278(31):29106-14. PubMed ID: 12750386
[TBL] [Abstract][Full Text] [Related]
11. Siah-1 facilitates ubiquitination and degradation of synphilin-1.
Nagano Y; Yamashita H; Takahashi T; Kishida S; Nakamura T; Iseki E; Hattori N; Mizuno Y; Kikuchi A; Matsumoto M
J Biol Chem; 2003 Dec; 278(51):51504-14. PubMed ID: 14506261
[TBL] [Abstract][Full Text] [Related]
12. Synphilin-1 enhances α-synuclein aggregation in yeast and contributes to cellular stress and cell death in a Sir2-dependent manner.
Büttner S; Delay C; Franssens V; Bammens T; Ruli D; Zaunschirm S; de Oliveira RM; Outeiro TF; Madeo F; Buée L; Galas MC; Winderickx J
PLoS One; 2010 Oct; 5(10):e13700. PubMed ID: 21060871
[TBL] [Abstract][Full Text] [Related]
13. Parkin and defective ubiquitination in Parkinson's disease.
Dawson TM
J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
[TBL] [Abstract][Full Text] [Related]
14. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
[TBL] [Abstract][Full Text] [Related]
15. Parkin accumulation in aggresomes due to proteasome impairment.
Junn E; Lee SS; Suhr UT; Mouradian MM
J Biol Chem; 2002 Dec; 277(49):47870-7. PubMed ID: 12364339
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease.
Marx FP; Holzmann C; Strauss KM; Li L; Eberhardt O; Gerhardt E; Cookson MR; Hernandez D; Farrer MJ; Kachergus J; Engelender S; Ross CA; Berger K; Schöls L; Schulz JB; Riess O; Krüger R
Hum Mol Genet; 2003 Jun; 12(11):1223-31. PubMed ID: 12761037
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders.
Wakabayashi K; Engelender S; Tanaka Y; Yoshimoto M; Mori F; Tsuji S; Ross CA; Takahashi H
Acta Neuropathol; 2002 Mar; 103(3):209-14. PubMed ID: 11907799
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation.
Avraham E; Rott R; Liani E; Szargel R; Engelender S
J Biol Chem; 2007 Apr; 282(17):12842-50. PubMed ID: 17327227
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
Trimmer PA; Borland MK; Keeney PM; Bennett JP; Parker WD
J Neurochem; 2004 Feb; 88(4):800-12. PubMed ID: 14756800
[TBL] [Abstract][Full Text] [Related]
20. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]